Agios Pharmaceuticals Executive Compensation
Agios Pharmaceuticals is a publicly traded company in the Healthcare sector.
Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Agios Pharmaceuticals discloses FY2025 compensation for 4 named executive officers, totaling $1.3M. Brian Goff, the Executive Officer, accounts for 44% of that combined total.
Brian Goff's total compensation fell 18% year-over-year, from $719,423 in FY2024 to $592,804 in FY2025.
Among 78 other Healthcare companies in this dataset, Agios Pharmaceuticals's combined tracked executive pay of $1.3M ranks in the 9th percentile (industry median: $13.6M). Its highest-paid executive, Brian Goff, ranks in the 6th percentile for top-executive pay in the sector (industry median: $6.3M).
Compensation figures on this page for Agios Pharmaceuticals come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.